Jubilant Ingrevia Q4 Revenue Rises 12 Per Cent

27 May 2026 CW Team

Jubilant Ingrevia reported a healthy performance in Q4 FY26, with revenue rising 12 per cent year-on-year and EBITDA increasing 11 per cent year-on-year. The company said strong execution, resilient demand and effective handling of Middle East disruptions supported its quarterly performance.

The company highlighted that it faced no force majeure and recorded zero production loss during the Middle East crisis. It also achieved successful dispatch from its newly constructed Agro CDMO facility and completed the acquisition of Remidex to accelerate growth in its Human Nutrition business.

The Board recommended a final dividend of Rs 2.50 per share, taking the total FY26 dividend to Rs 5 per share. The company said demand across the chemical industry remains resilient, with volumes growing and pricing firming up due to higher crude-linked costs.

Pharmaceuticals continued to support growth through strong volumes and steady demand, while the agrochemicals business saw strong export visibility and price increases. Nutrition and Personal Care markets also grew, driven by Niacinamide and demand across Feed and Cosmetics.

For FY27, Jubilant Ingrevia expects growth to be led by Specialty Chemicals and Nutrition, supported by recovery in Acetyls. The company also said construction of its Gajraula Multi Purpose Plant is progressing well and will strengthen its CDMO growth roadmap.

Infrastructure Urban

27 May 2026

Puravankara Secures 14.57 Acre Parcel In Mandur Bengaluru

Puravankara has secured a 14.57-acre land parcel in Mandur, Budigere, Bengaluru, with a potential gross development value of Rs 23 billion (Rs 23 bn). Of this, seven point nine two acres will be developed under a joint development agreement, and six point six five acres have been purchased outright. The project is expected to yield one point eight million square feet (1.8 million square feet) of saleable area. The company's developable area in Bengaluru is reported at 25.61 million square feet (25.61 million square feet). The managing director said the acquisition forms part of efforts to add ..

Royal Orchid Reports FY26 Results And Declares 25 Per Cent Dividend

Royal Orchid Hotels Limited announced audited financial results for the quarter and year ended 31 March 2026 and declared a 25 per cent dividend following board approval. The company, one of India’s fastest growing hospitality groups with 120 hotels nationwide, reported resilient performance driven by strategic portfolio expansion, improved operational efficiencies and robust demand across business and leisure markets. The board attributed results to steady revenue expansion and disciplined cost management. On a consolidated basis for FY26 total income rose to Rs 4.0643 billion (bn) from Rs ..

Man Industries Delivers Record Margins And Strong FY26 Results

Man Industries (India) Limited (MAN Industries) reported results for the quarter and fiscal year ended 31 March 2026, delivering highest-ever standalone and consolidated EBITDA and PAT margins as the company optimised product and geographic mix and deepened its global order pipeline. Standalone revenue in the fourth quarter rose 36 per cent year-on-year to Rs 11.57 bn, while consolidated revenue grew 36.2 per cent on a like-for-like basis after adjusting for Rs 3.69 bn of one-time real estate income from Merino Shelters in the prior-year quarter. On a standalone basis FY26 EBITDA margin reache..